Picture of Lumos Diagnostics Holdings logo

LDX Lumos Diagnostics Holdings Cashflow Statement

0.000.00%
au flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapNeutral

Annual cashflow statement for Lumos Diagnostics Holdings, fiscal year end - June 30th, USD millions except per share, conversion factor applied.

2019
June 30th
2020
June 30th
R2021
June 30th
2022
June 30th
2023
June 30th
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:
fx
Final
fx
Final
FinalFinalFinal
Changes in Working Capital1.820.1910.0170.021
Net Change in Other Assets & Liabilities
Other Operating Cash Flow
Cash from Operating Activities-3.09-3.65-10.9-18-9.64
Capital Expenditures-2.57-6.33-8.33-4.36-0.155
Purchase of Fixed Assets
Software Development Costs
Other Investing Cash Flow Items-5.814.46
Acquisition of Business
Sale of Fixed Assets
Purchase of Investments
Cash from Investing Activities-8.38-6.33-8.33-4.364.31
Financing Cash Flow Items-0.134
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities14.37.8863.3-10.90.652
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash2.89-2.144-36.9-4.96